Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pretreatment 18-FDG-PET/CT parameters can serve as prognostic imaging biomarkers in recurrent NSCLC patients treated with reirradiation-chemoimmunotherapy.
Grambozov B, Kalantari F, Beheshti M, Stana M, Karner J, Ruznic E, Zellinger B, Sedlmayer F, Rinnerthaler G, Zehentmayr F. Grambozov B, et al. Among authors: karner j. Radiother Oncol. 2023 Aug;185:109728. doi: 10.1016/j.radonc.2023.109728. Epub 2023 Jun 9. Radiother Oncol. 2023. PMID: 37301259 Free article.
Noninvasive inter- and intrafractional motion control in ultrahypofractionated radiation therapy of prostate cancer using RayPilot HypoCath™-a substitute for gold fiducial-based IGRT?
Berchtold J, Winkler C, Karner J, Groher M, Gaisberger C, Sedlmayer F, Wolf F. Berchtold J, et al. Among authors: karner j. Strahlenther Onkol. 2024 Mar;200(3):195-201. doi: 10.1007/s00066-023-02125-2. Epub 2023 Aug 25. Strahlenther Onkol. 2024. PMID: 37626226 Free PMC article.
Human skin-resident CD8+ T cells require RUNX2 and RUNX3 for induction of cytotoxicity and expression of the integrin CD49a.
Zitti B, Hoffer E, Zheng W, Pandey RV, Schlums H, Perinetti Casoni G, Fusi I, Nguyen L, Kärner J, Kokkinou E, Carrasco A, Gahm J, Ehrström M, Happaniemi S, Keita ÅV, Hedin CRH, Mjösberg J, Eidsmo L, Bryceson YT. Zitti B, et al. Among authors: karner j. Immunity. 2023 Jun 13;56(6):1285-1302.e7. doi: 10.1016/j.immuni.2023.05.003. Epub 2023 Jun 2. Immunity. 2023. PMID: 37269830
Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine.
Naaber P, Tserel L, Kangro K, Punapart M, Sepp E, Jürjenson V, Kärner J, Haljasmägi L, Haljasorg U, Kuusk M, Sankovski E, Planken A, Ustav M, Žusinaite E, Gerhold JM, Kisand K, Peterson P. Naaber P, et al. Among authors: karner j. Cell Rep Med. 2022 Aug 16;3(8):100716. doi: 10.1016/j.xcrm.2022.100716. Epub 2022 Aug 4. Cell Rep Med. 2022. PMID: 35952669 Free PMC article.
Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III.
Stana M, Grambozov B, Gaisberger C, Karner J, Ruznic E, Berchtold J, Zellinger B, Moosbrugger R, Studnicka M, Fastner G, Sedlmayer F, Zehentmayr F. Stana M, et al. Among authors: karner j. Diagnostics (Basel). 2022 Apr 19;12(5):1027. doi: 10.3390/diagnostics12051027. Diagnostics (Basel). 2022. PMID: 35626183 Free PMC article.
High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC.
Grambozov B, Stana M, Kaiser B, Karner J, Gerum S, Ruznic E, Zellinger B, Moosbrugger R, Studnicka M, Fastner G, Sedlmayer F, Zehentmayr F. Grambozov B, et al. Among authors: karner j. Cancers (Basel). 2022 Jan 23;14(3):573. doi: 10.3390/cancers14030573. Cancers (Basel). 2022. PMID: 35158841 Free PMC article. Review.
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3.
Zellinger B, Bodenhofer U, Engländer IA, Kronberger C, Grambozov B, Ruznic E, Stana M, Karner J, Fastner G, Sotlar K, Sedlmayer F, Zehentmayr F. Zellinger B, et al. Among authors: karner j. Breast Cancer. 2022 Mar;29(2):274-286. doi: 10.1007/s12282-021-01308-y. Epub 2021 Dec 5. Breast Cancer. 2022. PMID: 34865205 Free PMC article.
117 results